Sotac Pharmaceuticals Ltd Annually Results

Gross Sales

96.99

103.83

77.48

48.84

28.6

Excise Duty

0

0

0

0

0

Net Sales

96.99

103.83

77.48

48.84

28.6

Other Operating Income

0

0

0

0

0

Other Income

3.9

0.49

0.93

0.11

0.22

Total Income

100.88

104.32

78.41

48.95

28.83

Total Expenditure

83.35

95.55

70.23

47.39

26.74

PBIDT

17.53

8.77

8.18

1.56

2.08

Interest

2.58

1.7

1.98

1.02

0.33

PBDT

14.95

7.06

6.2

0.54

1.76

Depreciation

3.84

3.1

2.28

2.59

1.4

Minority Interest Before NP

0

0

0

0

0

Tax

1.72

2.09

1.68

0.42

0.25

Deferred Tax

0.13

-1.7

-0.04

-0.11

0.02

Reported Profit After Tax

9.28

3.58

2.29

-2.37

0.09

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

8.03

4.28

2.88

-2.37

0.09

Extra-ordinary Items

0

-0.11

0.33

0

0

Adjusted Profit After Extra-ordinary item

8.03

4.39

2.55

-2.37

0.09

EPS (Unit Curr.)

7.26

3.9

3.58

-10.28

0.89

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

11.05

11.05

8.05

2.3

2.3

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

18.07

8.44

10.55

3.19

7.27

PBDTM(%)

15.41

6.79

8

1.1

6.15

PATM(%)

9.56

3.44

2.95

-4.85

0.31